Azurity Pharmaceuticals Mergers & Acquisitions

Azurity Pharmaceuticals M&A Summary

Azurity Pharmaceuticals has acquired 5 companies of its own, including 4 in the last 5 years. A total of 3 acquisitions came from private equity firms.

Azurity Pharmaceuticals has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity5
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2

Azurity Pharmaceuticals

Azurity Pharmaceuticals, Inc.

8 Cabot Road, Suite 2000,
Woburn, Massachusetts 01801
United States,
(877) 495-6858
www.azurity.com

All (5) Buy (5) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2025-11-17 Sebela Pharmaceuticals - Bowel Prep Franchise · Life Science
Roswell, Georgia

Sebela Pharmaceuticals' Bowel Prep Franchise includes prescription therapies for colonoscopy preparation and is based in Roswell, Georgia.

- Divestiture

Azurity Pharmaceuticals
Advisors: Barclays Investment Bank , Eversheds Sutherland

Sebela Pharmaceuticals
Advisors: Jefferies , Mayer Brown


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.